Is Mako the real deal?

Discussion in 'Stryker' started by Anonymous, Apr 20, 2015 at 1:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    If you know the numbers then you are on the inside in corporate, sales or marketing and are not an investor and full of sh#t.
     

  2. anonymous

    anonymous Guest

    Quiet here. Everyone must be out selling makos.
     
  3. anonymous

    anonymous Guest

    Investor here. 31 sold in q4 2015. 20 in q4 2014. 55% increase yoy. This is starting to gain traction. Too many nay sayers on this board.
     
  4. anonymous

    anonymous Guest

    We all live in the real world where we see it for what it is. Have fun with your numbers....
     
  5. anonymous

    anonymous Guest

    Real world for me too, 4 competitive hip surgeons now using MAKO. 7 months 4 conversions, things are going ok for me in the real world. Once again, not for all of the surgeons, but the ones that see the value, love it. Should be close to 1.5 million in new business. (And now all of the bashing can continue)
     
  6. anonymous

    anonymous Guest

    If you are in the right area this can make you money, I grant you that. But I just don't feel any sort of groundswell to adopt robots, and I don't know anyone who put off adopting robot technology waiting for total hip and knee applications. Sorry, this is a niche product.
     
  7. anonymous

    anonymous Guest

    Definitely think younger surgeons who are into technology are more likely to adopt Mako so the future on this looks very bright.
     
  8. anonymous

    anonymous Guest

    Still the biggest users and the surgeons everyone reference are ALL getting paid to use mako. One big marketing scheme to try and get Capital sales tied into total joint contracts to get market share at hospitals. Good idea that turned sour fast, and the price Stryker paid for mako.... Yikes.
     
  9. anonymous

    anonymous Guest

    Absolutely no clinical difference from traditional tka in multiple studies now. I take that back, added OR time is the biggest complaint/difference now.
     
  10. anonymous

    anonymous Guest

    What are your sources for the study data? Corporate? So if clinical difference/advantage is a wash and the procedure adds OR time, how is this better than traditional tka? How do you sell this and convert surgeons? Throw in the CT is issue (if in fact that is a show stopper) and I don't see any benefit to MAKO. Can we here from some other reps on this?
     
  11. anonymous

    anonymous Guest

    Quiet in here. Everyone out selling robots or what?
     
  12. anonymous

    anonymous Guest

    robots are the future for all surgery, joints, spine and next will be even trauma and nailing. And not just MAKO there are competitors in all these area. Multiple spine robots now and even J&J and Google teaming to make the next generation ortho robots. MAKO may not be the best at the end of the day but they have the head start. Even from a marketing and legal protection perspective they make sense.
     
  13. anonymous

    anonymous Guest

    Robots are for charlatans and goof balls.
     
  14. anonymous

    anonymous Guest

    Awfully quiet in here. To other reps: how were q1 mako sales for you? Are you still seeing the ct reimbursement issue? Any conversions to mako? Overall feeling in the field on mako?
     
  15. anonymous

    anonymous Guest

    Mako is dead to basically anyone not being paid to put it in. Sales could care less, surgeons don't want the hassle of ct insurance approval, and blue belt is gaining ground with more ex mako employees on board.
     
  16. anonymous

    anonymous Guest

    Insurance may no longer pay for scans!? This news could change the entire mako idea!
     
  17. anonymous

    anonymous Guest

    The cost of a scan is minimal compared to the cost of readmission. This is a tired argument. The robot trend will continue and will most likely require scans.

    The major contributor to cost is post acute care, not a $150 scan or implants. The only way to really effect the 90 day episode is by driving clinical results and operational standardization. Line item cost reduction and cheap implants cannot get it done.
     
  18. anonymous

    anonymous Guest

    yes
     
  19. anonymous

    anonymous Guest

    conversions happening quickly in my territory. 7 docs and roughly ~600 joints over the last year. I have 3 accounts with robots and a 4th about to purchase. If you're not allocating the vast majority of your time developing your business around MAKO, you are doing yourself a huge disservice.